Pharmaceuticals Anonymous

Friday, February 6, 2009

Terry Pratchett: On His Alzheimer's




UPDATE: Aug. 9 2009
Pratchett is fighting for the right to die.
Link
Not so fast, Sir Terence: Alzheimer's may not be what your medical experts tell you it is. See
Harold Foster.
http://web.archive.org/web/20060526175827/http://www.hdfoster.com/Foster_Alzheimers.pdf




From The Times
January 30, 2009
Discworld author Terry Pratchett on Alzheimer's and his best work
The Discworld author is funny, fluent and channelling the anger towards his Alzheimer's disease into some of his best work


Andrew Billen

The Talmud decrees that to save one life is to save the world. If scientific research can save Sir Terry Pratchett from Alzheimer's disease, then it will also save Discworld, the fantastical other Earth that the novelist has chronicled in 36 books. Discworld is a flattish disc that rests on four elephants standing on an enormous turtle - but you probably know that, even if you have never read Pratchett. The idea is such a delightful joke, both on creation myths and the more pompous strains of fantasy fiction, that it resonates. As a young fan interviewed on a two-part BBC documentary that follows Pratchett's first year from diagnosis, says: “How could a great mind like that be lost?” I try the thought out on Pratchett, that for intellectuals, such as Bernard Levin or Iris Murdoch, the disease is particularly cruel. “Yes, isn't that a pile of c***?” he replies. “It is a tragedy for everybody. Or, if it is a tragedy for anyone, then it is tragedy for everyone.”

You need to be careful when talking to Pratchett on this matter. For a start he has a particular strain of Alzheimer's called Posterior Cortical Atrophy (PCA) and its symptoms are different. Second, he does not think it makes him special. Over the new year, Edward Stourton on the Today programme on Radio 4 made the mistake of linking his knighthood with the news of his illness, released on the web 13 months ago, a few months before his 60th birthday. Pratchett retorted that he hoped he was being recognised for more than getting ill. He let Stourton off when he said he was referring to the way he had addressed the condition. Stourton was lucky. I get into trouble for saying that having a film crew accompany him as he investigated his own prognosis must have been a “sacrifice”.

“You see, there you go again. It seemed to me absolutely natural because I had to tell people and I thought, ‘Well why be bashful about it?' It's not as if I'd done something wrong. In too many people's minds Alzheimer's is considered madness. It is a physical disease that affects the brain.” In fact, he will admit that the campaigning - not just the television but a visit to Downing Street, where Gordon Brown personally made him a cup of tea and, what is more, listened, a pledge to give a million dollars in research, appearances at support groups and so on - has cost him “half a book”. This is a sacrifice, for he must keep writing.

“Otherwise I'm just Terry Pratchett, ‘the sufferer'. It's all part of our modern culture. We like people to be sufferers because then we can pity them.” He doesn't then want a movie made of his “battle”, such as that Iris Murdoch film? “No. I think three different researchers wrote to me asking could I help them with work on analysing my style as the illness progresses, and I wrote back, 'What I like about vultures is that they wait until the donkey is dead'. I just couldn't believe that they would try that.”
Link

About his television program on living with Alzheimer's
Link

How the Bailout Benefits Big Pharma - and YOU Will Pay For It


At about the 1:20 mark, Mr. Kucinich mentions Pfizer's $68 Billion buyout of Wyeth - for which YOU will pay. The New York times article link is here.

Thursday, February 5, 2009

Rest in Peace, Lux

Lux Interior, founder and lead singer of the punkabilly group the Cramps, has died.
Here he performs for patients inside Napa State Mental Hospital.

http://en.wikipedia.org/wiki/The_Cramps

Tuesday, February 3, 2009

Alzheimer's and B3/Niacin


Vitamin B3/Niacin as Alzheimer's therapy:
"Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or delay its onset are urgently needed. Effective preventive strategies likely offer the greatest and most widespread benefits. Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance memory and synaptic plasticity. We evaluated the efficacy of nicotinamide, a competitive inhibitor of the sirtuins or class III NAD+-dependent HDACs in 3xTg-AD mice, and found that it restored cognitive deficits associated with pathology. Nicotinamide selectively reduces a specific phospho-species of tau (Thr231) that is associated with microtubule depolymerization, in a manner similar to inhibition of SirT1. Nicotinamide also dramatically increased acetylated -tubulin, a primary substrate of SirT2, and MAP2c, both of which are linked to increased microtubule stability. Reduced phosphoThr231-tau was related to a reduction of monoubiquitin-conjugated tau, suggesting that this posttranslationally modified form of tau may be rapidly degraded. Overexpression of a Thr231-phospho-mimic tau in vitro increased clearance and decreased accumulation of tau compared with wild-type tau. These preclinical findings suggest that oral nicotinamide may represent a safe treatment for AD and other tauopathies, and that phosphorylation of tau at Thr231 may regulate tau stability."
Link
More here: Link
A link has been established between Alzheimer's and calcium - a substance we take like candy in antacids. Link
What is the counterbalance for calcium? Magnesium. What makes magnesium work better? Niacin....

Monday, February 2, 2009

Stop Bill C-51 Campaign Revived



It's baaaaack...Canada's vitamin-banning Bill C-51 has been reworked as Bill C-6.


Stop Bill C-51 -- CODEX ALIMENTARIUS -- Call to Action from Anonymai on Vimeo.

Who Owns Nature? Pharma, Of Course!

Monsantoland Pictures, Images and Photos

Further extracts from ETC Group's recently released report, "Who Owns Nature?" These are from the section about the pesticde industry. For the full report:
http://www.etcgroup.org/en/materials/publications.html?pub_id=707

According to the report, the world's six largest agrochemical manufacturers, who control nearly 75% of the global pesticide market, are also seed industry giants.

It's worth breaking this down by company.

Bayer: the world's biggest agrochemical company is also the world's seventh biggest seed company.

Syngenta: the world's second largest agrochemical company is also the world's third largest seed company.

Monsanto: the world's biggest seed company is the world's fifth largest agrochemical company.

And DuPont: the world's second biggest seed company is also the world's sixth largest agrochemical company.

All these companies are gene giants.

Weed killers (herbicides) account for about one-third of the global pesticide market, and around 80% of GM seeds involve herbicide-resistance.

The worldwide market for agrochemicals grew last year by nearly 10%.
------
Who Owns Nature?
Report from ETC Group

[Extracts only]

Agrochemical Industry

World's Top 10 Pesticide Firms

Company - Agrochemical Sales 2007 (US$ millions) - % Market Share

1.Bayer (Germany) - $7,458m - 19%
2.Syngenta (Switzerland) - $7,285m - 19%
3.BASF (Germany) - $4,297m - 11%
4.Dow AgroSciences (USA) - $3,779m - 10%
5.Monsanto (USA) - $3,599m - 9%
6.DuPont (USA) - $2,369m - 6%
7.Makhteshim Agan (Israel) - $1,895m - 5%
8.Nufarm (Australia) - $1,470m - 4%
9.Sumitomo Chemical (Japan) - $1,209m - 3%
10.Arysta Lifescience (Japan) - $1,035m - 3%
Total $34,396m - 89%
Source: Agrow World Crop Protection News, August 2008

The top 10 companies control 89% of the global agrochemical market.

The worldwide market for agrochemicals was US$38.6 billion in 2007 - up 8.4% over the previous year. The top 6 companies accounted for $28.8 billion, or 75% of the total market.


Link

Canada - take action on genetic modification here

Thursday, January 29, 2009

Rolling Stone article plagiarizes Furious Seasons

Furious Seasons blog owner and investigative journalist Philip Dawdy writes,

"This news brought to you courtesy of the Zyprexa documents, which Rolling Stone apparently used in reporting its recent lengthy story on Zyprexa, but didn't attribute to the appropriate source. They are just referred to as "internal documents" in the article, completely ignoring the very substantial risks some folks went to to make those documents public.
Yes, the RS article is now online and I've read it. I want to re-read it before deciding whether to take out a plinging gun or a .50 caliber machine gun.
Despite giving the reporter loads of help for his story and going unmentioned and unattributed, one thing I'll tell you right now is that the article is entitled "Bitter Pill." Ironically enough, last year I wrote an article for Willamette Week on how negative anti-depressant clinical trials data had been suppressed for decades. The article's title was "Bitter Pill." While article titles are up for grabs, it just charms me beyond belief that RS chose, coincidentally I'm sure, a title I'd already used. Classic."

RS article is here

A fine shout-out to Dawdy's giant-killing work at Furious Seasons is
here. - Why doesn't Rolling Stone hire Philip Dawdy?